Biomarkers for isolated congenital heart disease based on maternal amniotic fluid metabolomics analysis
Abstract Introduction Congenital heart disease (CHD) is one of the most prevalent birth defects in the world. The pathogenesis of CHD is complex and unclear. With the development of metabolomics technology, variations in metabolites may provide new clues about the causes of CHD and may serve as a bi...
Main Authors: | Xuelian Yuan, Lu Li, Hong Kang, Meixian Wang, Jing Zeng, Yanfang Lei, Nana Li, Ping Yu, Xiaohong Li, Zhen Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12872-022-02912-2 |
Similar Items
-
Metabolomics Signatures and Subsequent Maternal Health among Mothers with a Congenital Heart Defect-Affected Pregnancy
by: Ping-Ching Hsu, et al.
Published: (2022-01-01) -
Metabolomic Profiling of Adults with Congenital Heart Disease
by: Ari Cedars, et al.
Published: (2021-08-01) -
Metabolomics and random forests in patients with complex congenital heart disease
by: Miriam Michel, et al.
Published: (2022-10-01) -
Seminal plasma metabolomics signatures of normosmic congenital hypogonadotropic hypogonadism
by: Xiaogang Li, et al.
Published: (2023-04-01) -
Cytokine Profiling of Amniotic Fluid from Congenital Cytomegalovirus Infection
by: Nicolas Bourgon, et al.
Published: (2022-09-01)